OpenVSafe by OpenVAERS
Search V-safe

G8C-33751-87775

4 vaccinations 1 coded response 14 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
727 / AR
Registered
2021-04-22
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
C7C-26789-53689 Child or adolescent in my care · Female · 2022-06-30

Timeline

  1. 2021-04-22
    Registered in v-safe
  2. 2021-04-22
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-22
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  4. 2021-04-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  5. 2021-04-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-04-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-04-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-05-17
    Dose 2 — Pfizer-BioNTech
  10. 2021-05-17
    Health check-in — day 0, dose 2
    Feeling: Fair · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  11. 2021-06-28
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-08-17
    Survey response — 3 months, dose 2
    MedDRA: Postpartum state, Pre-eclampsia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization
    Free text: Preeclampsia and postpartum preeclampsia
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  13. 2021-08-17
    Report sent to call center — 3 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  14. 2021-08-22
  15. 2021-12-08
    Dose 3 — Moderna
    Co-administered: Flu
  16. 2022-05-17
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  17. 2022-06-25
    Dose 4 — Moderna
  18. 2022-06-30
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain · None
    Adult check-in
  19. 2022-07-01
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  20. 2022-07-02
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  21. 2023-06-27
    Health check-in — 12 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-22Pfizer-BioNTech
22021-05-17Pfizer-BioNTech
32021-12-08Moderna Flu
42022-06-25Moderna No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 9 — 3 months, dose 2

2021-08-17

Symptoms: Preeclampsia and postpartum preeclampsia

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDPostpartum state ✓ · ✓
SDPre-eclampsia ✓ · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…